Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 5/20 | 0.41 |
| ▸ | CALCA | P06881 | 2/20 | 0.40 |
| ▸ | PRCP | P42785 | 2/20 | 0.39 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.39 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.38 |
| ▸ | CPT1A | P50416 | 2/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31457053 | 1.00 | GRIN2B (0.41) | GRIN2BCALCAPRCPAADATTMEM97 | |
| SCHEMBL30751262 | 0.87 | MET (0.40) | GRIN2BPRCPAADATCPT1ACPT2 | |
| SCHEMBL31457006 | 0.87 | MET (0.40) | GRIN2BPRCPAADATCPT1ACPT2 | |
| SCHEMBL31457054 | 0.87 | MET (0.40) | GRIN2BPRCPAADATCPT1ACPT2 | |
| SCHEMBL30751331 | 0.87 | MET (0.40) | GRIN2BPRCPAADATCPT1ACPT2 | |
| SCHEMBL27376324 | 0.85 | CALCA (0.42) | CALCAAADATALDH1A1LMNAHPGD | |
| SCHEMBL31456925 | 0.85 | CALCA (0.42) | CALCAAADATALDH1A1LMNAHPGD | |
| SCHEMBL31457044 | 0.84 | AADAT (0.44) | GRIN2BAADATTMEM97SIGMAR1LMNA | |
| SCHEMBL31456986 | 0.84 | AADAT (0.44) | GRIN2BAADATTMEM97SIGMAR1LMNA | |
| SCHEMBL27376309 | 0.84 | CALCA (0.40) | GRIN2BCALCAPRCPCPT1ACPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4567035-A1 | NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Nextgen Bioscience Co., Ltd. (KR) | 2025-06-11 | — | — | EP | disclosed |
| WO-2024030000-A1 | NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 넥스트젠바이오사이언스 | 2024-02-08 | — | — | WO | disclosed |